![Adrian Quartel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Adrian Quartel
No open positions remaining
Net worth: 139 428 $ as of 30/06/2026
Profile
Adrian Quartel worked at BioMarin Pharmaceutical, Inc. from 2016 to 2020, serving as Head-Medical Affairs from 2017 to 2020.
From 2020 to 2022, worked at Adamas Pharmaceuticals LLC as Chief Medical Officer.
From 2022 to 2023, worked at Acer Therapeutics, Inc. as Chief Medical Officer.
Education includes a doctorate from Erasmus University Rotterdam and a graduate degree from The Royal College of Physicians.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/01/2026 | 9,723 ( 0.02% ) | 139 428 $ | 30/06/2026 |
Former positions of Adrian Quartel
| Companies | Position | End |
|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 03/07/2026 |
| ACER THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 01/01/2023 |
| ADAMAS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/02/2022 |
| BIOMARIN PHARMACEUTICAL INC. | Chief Tech/Sci/R&D Officer | 01/09/2020 |
Training of Adrian Quartel
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
28
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets therapeutics for neurological diseases | Health Technology |
Zevra Therapeutics, Inc.
 Zevra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets proprietary prodrugs | Health Technology |
Erasmus University Rotterdam
 Erasmus University Rotterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Royal College of Physicians
 The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acer Therapeutics, Inc.
 Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for serious rare and life-threatening diseases | Health Technology |
- Stock Market
- Insiders
- Adrian Quartel
Choose MarketScreener 
